Mark S. Davis's most recent trade in Yext Inc was a trade of 43,209 Restricted Stock Unit done . Disclosure was reported to the exchange on June 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Yext Inc | Mark S. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2026 | 43,209 | 43,209 | - | - | Restricted Stock Unit | |
| Yext Inc | Mark S. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,131 | 89,631 (0%) | 0% | - | Common Stock | |
| Yext Inc | Mark S. Davis | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jun 2026 | 27,131 | 0 | - | - | Restricted Stock Unit | |
| Myriad Genetics Inc | Mark S. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2026 | 59,701 | 106,665 (0%) | 0% | 0 | Common Stock | |
| Yext Inc | Mark S. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 27,131 | 27,131 | - | - | Restricted Stock Unit | |
| Myriad Genetics Inc | Mark S. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 24,148 | 46,964 (0%) | 0% | 0 | Common Stock |